Mind Medicine Earnings Estimate

MNMD Stock  USD 6.72  0.02  0.30%   
The next projected EPS of Mind Medicine is estimated to be -0.370725 with future projections ranging from a low of -0.43 to a high of -0.315. Mind Medicine's most recent 12-month trailing earnings per share (EPS TTM) is at -1.71. Please be aware that the consensus of earnings estimates for Mind Medicine is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Covid
Mind Medicine is projected to generate -0.370725 in earnings per share on the 31st of December 2024. Mind Medicine earnings estimates show analyst consensus about projected Mind Medicine EPS (Earning Per Share). It derives the highest and the lowest estimates based on Mind Medicine's historical volatility. Many public companies, such as Mind Medicine, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Mind Medicine's earnings estimates, investors can diagnose different trends across Mind Medicine's analyst sentiment over time as well as compare current estimates against different timeframes. As of March 2, 2025, Gross Profit is expected to decline to about (3 M)
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mind Medicine. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For information on how to trade Mind Stock refer to our How to Trade Mind Stock guide.

Mind Medicine Earnings Estimation Breakdown

The calculation of Mind Medicine's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Mind Medicine is estimated to be -0.370725 with the future projection ranging from a low of -0.43 to a high of -0.315. Please be aware that this consensus of annual earnings estimates for Mind Medicine is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
-0.27
-0.43
Lowest
Expected EPS
-0.370725
-0.32
Highest

Mind Medicine Earnings Projection Consensus

Suppose the current estimates of Mind Medicine's value are higher than the current market price of the Mind Medicine stock. In this case, investors may conclude that Mind Medicine is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Mind Medicine's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of December 2024Current EPS (TTM)
1173.45%
-0.27
-0.370725
-1.71

Mind Medicine Earnings per Share Projection vs Actual

Actual Earning per Share of Mind Medicine refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Mind Medicine predict the company's earnings will be in the future. The higher the earnings per share of Mind Medicine, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Mind Medicine Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Mind Medicine, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Mind Medicine should always be considered in relation to other companies to make a more educated investment decision.

Mind Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Mind Medicine's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-11-07
2024-09-30-0.28-0.270.01
2024-08-13
2024-06-30-0.33-0.260.0721 
2024-05-08
2024-03-31-0.53-1.14-0.61115 
2024-02-28
2023-12-31-0.46-0.59-0.1328 
2023-11-02
2023-09-30-0.67-0.450.2232 
2023-08-03
2023-06-30-0.54-0.76-0.2240 
2023-05-04
2023-03-31-0.42-0.52-0.123 
2023-03-09
2022-12-31-0.5-0.160.3468 
2022-11-10
2022-09-30-0.6-0.560.04
2022-08-11
2022-06-30-0.75-0.60.1520 
2022-05-16
2022-03-31-0.75-0.60.1520 
2022-03-28
2021-12-31-0.7-0.75-0.05
2021-11-12
2021-09-30-0.52-0.9-0.3873 
2021-08-12
2021-06-30-0.6-1.35-0.75125 
2021-05-14
2021-03-31-0.23-0.040.1982 
2021-03-30
2020-12-31-0.3-0.150.1550 
2020-11-13
2020-09-30-0.45-0.450.0
2020-08-13
2020-06-300-0.03-0.03
2020-05-14
2020-03-310-0.03-0.03

About Mind Medicine Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Mind Medicine earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Mind Medicine estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Mind Medicine fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-261.2 M-248.1 M
Retained Earnings Total Equity-175 M-183.8 M
Earnings Yield(0.60)(0.63)
Price Earnings Ratio(1.72)(1.81)
Price Earnings To Growth Ratio(0.02)(0.02)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Mind Medicine is a strong investment it is important to analyze Mind Medicine's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Mind Medicine's future performance. For an informed investment choice regarding Mind Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mind Medicine. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For information on how to trade Mind Stock refer to our How to Trade Mind Stock guide.
You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mind Medicine. If investors know Mind will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mind Medicine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.71)
Return On Assets
(0.25)
Return On Equity
(0.55)
The market value of Mind Medicine is measured differently than its book value, which is the value of Mind that is recorded on the company's balance sheet. Investors also form their own opinion of Mind Medicine's value that differs from its market value or its book value, called intrinsic value, which is Mind Medicine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mind Medicine's market value can be influenced by many factors that don't directly affect Mind Medicine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mind Medicine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mind Medicine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mind Medicine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.